Author

Carlo Bruno Bifulco

Providence Health & ServicesORCID 0000-0003-1922-6977Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:variant calling· 2 Assay:whole-genome sequencing· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:phylogenetics / evolution· 1

Frequent Co-Authors

Brian PieningiD· 2 shared Alexa K. DowdelliD· 1 shared Andrew T. MagisiD· 1 shared Ann VitaiD· 1 shared Bela Bapat· 1 shared Benjamin A. Cosgrove· 1 shared Brock Schroeder· 1 shared Cliff WongiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Brian PieningORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicineFrontiers in Molecular BiosciencesPeer-reviewedOct 13, 2025

Design and validation of a clinical whole genome sequencing-based assay for patient screening in a large healthcare system

Josiah T. Wagner, John T. Welle, Isabelle Lucas Beckett…·Brian Piening

The paper develops and validates a clinical whole genome sequencing assay for heritable disease and pharmacogenomics testing, showing high sensitivity, specificity, and accuracy in a large cohort.

1 citation

humanwhole-genome sequencing

𝕏 PostBluesky

Genetic & Genomic MedicineJCO Oncology PracticePeer-reviewedNov 1, 2024

Widespread adoption of precision anticancer therapies after implementation of pathologist-directed comprehensive genomic profiling across a large US health system

Alexa K. Dowdell, Ryan Meng, Ann Vita…·Brian Piening

This study shows that precision therapies have become more common than traditional chemotherapy in advanced cancer patients after implementing comprehensive genomic profiling.

13 citations

humanwhole-exome sequencing

𝕏 PostBluesky